Back to Search Start Over

Frequency and phenotypic spectrum of spinocerebellar ataxia 27B and other genetic ataxias in a Spanish cohort of late‐onset cerebellar ataxia.

Authors :
Iruzubieta, Pablo
Pellerin, David
Bergareche, Alberto
Albajar, Inés
Mondragón, Elisabet
Vinagre, Ana
Fernández‐Torrón, Roberto
Moreno, Fermín
Equiza, Jon
Campo‐Caballero, David
Poza, Juan José
Ruibal, Marta
Formica, Alessandro
Dicaire, Marie‐Josée
Danzi, Matt C.
Zuchner, Stephan
Croitoru, Ioana
Ruiz, Montserrat
Schlüter, Agatha
Casasnovas, Carlos
Source :
European Journal of Neurology; Dec2023, Vol. 30 Issue 12, p3828-3833, 6p
Publication Year :
2023

Abstract

Background and purpose: Dominantly inherited GAA repeat expansions in the fibroblast growth factor 14 (FGF14) gene have recently been shown to cause spinocerebellar ataxia 27B (SCA27B). We aimed to study the frequency and phenotype of SCA27B in a cohort of patients with unsolved late‐onset cerebellar ataxia (LOCA). We also assessed the frequency of SCA27B relative to other genetically defined LOCAs. Methods: We recruited a consecutive series of 107 patients with LOCA, of whom 64 remained genetically undiagnosed. We screened these 64 patients for the FGF14 GAA repeat expansion. We next analysed the frequency of SCA27B relative to other genetically defined forms of LOCA in the cohort of 107 patients. Results: Eighteen of 64 patients (28%) carried an FGF14 (GAA)≥250 expansion. The median (range) age at onset was 62.5 (39–72) years. The most common clinical features included gait ataxia (100%) and mild cerebellar dysarthria (67%). In addition, episodic symptoms and downbeat nystagmus were present in 39% (7/18) and 37% (6/16) of patients, respectively. SCA27B was the most common cause of LOCA in our cohort (17%, 18/107). Among patients with genetically defined LOCA, SCA27B was the main cause of pure ataxia, RFC1‐related disease of ataxia with neuropathy, and SPG7 of ataxia with spasticity. Conclusion: We showed that SCA27B is the most common cause of LOCA in our cohort. Our results support the use of FGF14 GAA repeat expansion screening as a first‐tier genetic test in patients with LOCA. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
13515101
Volume :
30
Issue :
12
Database :
Complementary Index
Journal :
European Journal of Neurology
Publication Type :
Academic Journal
Accession number :
173516191
Full Text :
https://doi.org/10.1111/ene.16039